Christian, J.S., "A Review of the Pharmacology, Clinical Applications, and Toxicology of Thymopentin, " Transgenica: The Journal of Clinical Biotechnology, 1, pp. 23-34 (1994). |
Prezioso et al., ".gamma.-Glutamyltranspeptidase Expression Regulates the Growth-Inhibitory Activity of Anti-Tumor Prodrug .gamma.-L-gultaminyl-4-hydroxy-3-iodobenzene," Int. J. Cancer, 56, pp. 874-879 (1994). |
Li Kam Wa et al., "The Antinatriuretic Action of .gamma.-L-glutamyl-5-hydroxy-L-tryptophan is Dependent on its Decarboxylation to 5-hydroxytryptamine in Normal Man," Br. J. Clin. Pharmac., 387, pp. 265-269 (1994). |
Illum, Lisbeth, "The Nasal Delivery of Peptides and Proteins," Trends in Biotechnology, 9, pp. 284-289 (1991). |
Goldstein et al., "Thymopoietin to Thymopentin: Experimental Studies," Thymopentin in Experimental and Clinical Medicine, Survey of Immunologic Research, 4, Supp. 1, pp. 1-10 (1985). |
Gillis et al., "T-Cell Growth Factor: Parameters of Production and Quantitative Assay for Activity," J. Immunol., 120:6, pp. 2027-2032 (1978). |
Hasegawa et al., Agric. Biol. Chem., vol. 42, No. 2, pp. 371-381, (1978). |
Wellner, Methods in Onyymology, vol. 113, 1985 pp. 564-566. |
Hirata, Bulletin of the Chemical Society of Japan, vol. 45, No. 6, 1972 pp. 1790-1794. |